
Dolby Laboratories (DLB) Stock Forecast & Price Target
Dolby Laboratories (DLB) Analyst Ratings
Bulls say
Dolby Laboratories Inc. reported total revenues of $307.0 million, reflecting a year-over-year increase of approximately 1%, while full-year total revenue rose 5.9% with significant contributions from licensing revenue (up 5.6%) and product/services revenue (up 10%). The company's operating margins improved to 33.2%, up from 31.2%, indicating enhanced profitability alongside revenue growth. Furthermore, the adoption of Dolby's technologies, including its SaaS-like models for patent licensing and increasing demand for Dolby Vision capture in key markets like China and India, underscores the potential for sustainable growth in a competitive industry.
Bears say
Dolby Laboratories is projecting a revenue decline in fiscal 2026, with expectations of a high-single-digit decrease, mirroring trends observed in fiscal 2025. Management has also revised growth expectations for its Atmos/Vision/Patents business downward to 15% to 20%, reflecting a cautious outlook on future revenues. Additionally, gross margins have contracted to 89.7% from 90.1%, indicating potential pressures on profitability amid ongoing market challenges and declining device volumes linked to a post-pandemic environment.
This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares